Explore more publications!

The Africa Gazette: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Africa Gazette.

Press releases published on September 25, 2025

NevGold Releases Significant Oxide Gold-Antimony Results: 11.41 g/t AuEq Over 6.1 Meters (10.60 g/t Au And 0.18% Antimony) Within 2.19 g/t AuEq Over 56.4 Meters (1.74 g/t Au And 0.10% Antimony) at the Limousine Butte Project, Nevada
Clene Presents New Clinical Data at ECTRIMS 2025 Meeting Demonstrating CNM-Au8® Improves Brain Energy Metabolism in Multiple Sclerosis Patients
Cardiac Biotech Solutions, Inc. Secures Health Canada License for MyCardia AT Device, Now Branded as CardioHolter AT
Cosmos Health Expands Order Book with Contract Manufacturing Agreement with Medical Pharmaquality S.A. for 3 Million MYCOFAGYL® Pessaries Annually
Clearmind Medicine’s Convenes Inaugural Scientific Advisory Board Meeting to Advance Psychedelic-Derived Therapies
Dynacor Group Declares October 2025 Dividend
Groupe Dynacor déclare son dividende pour octobre 2025
ValOre Strengthens Leadership Team With the Appointment of Nick Smart as C.E.O.
Wesdome Appoints Philip C. Yee as Chief Financial Officer
RetinalGenix Technologies Advances Home and Remote Monitoring Patent Portfolio, Positioning for the Future of Ocular and Systemic Disease Care
First Atlantic Nickel Doubles RPM Zone Strike Length to 800 Meters at Pipestone XL Nickel Alloy Project with 491 Meter Awaruite (Ni3Fe) Intercept in Phase 2X Drilling
VarmX receives Phase 1 waiver from Japanese regulator PMDA for lead asset VMX-C001
ヴァルムエックス (VarmX)、日本の規制当局である医薬品医療機器総合機構 (PMDA) からリード資産VMX-C001に対する第I相試験免除を取得
PU Prime Proudly Sponsors MoneyShow Toronto 2025
PU Prime est fier de parrainer le MoneyShow Toronto 2025
Sapu Nano’s Sapu003 Advances to Human Clinical Testing - Transforming Everolimus Delivery with Full Bioavailability for Breast Cancer Patients
Sapu Nano’s Sapu003 Advances to Human Clinical Testing - Transforming Everolimus Delivery with Full Bioavailability for Breast Cancer Patients

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions